Patents by Inventor Tatjana Sumanovac Ramljak

Tatjana Sumanovac Ramljak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8389505
    Abstract: The invention relates to adamantane diaza-crown ether derivatives and the use of mono and diaza-crown ether adamantine derivatives in treatment, especially in tumor treatment. Adamantane aza-crown ethers were obtained by reaction of the corresponding adamantane derived tosylates or adamantane acid chlorides with mono- and diaza-18-crown-6. The prepared compounds showed moderate (monoaza-18-crown-6) to strong (diaza-18-crown-6) antiproliferative and cytotoxic activity on several tumor cell lines, revealing their potential for inhibiting the growth of other tumor cells.
    Type: Grant
    Filed: May 13, 2011
    Date of Patent: March 5, 2013
    Assignee: Rudjer Boskovic Institute
    Inventors: Marijeta Kralj, Kata Majerski, Tatjana Sumanovac Ramljak, Marko Marjanovic
  • Publication number: 20110257254
    Abstract: The invention relates to adamantane diaza-crown ether derivatives and the use of mono and diaza-crown ether adamantine derivatives in treatment, especially in tumor treatment. Adamantane aza-crown ethers were obtained by reaction of the corresponding adamantane derived tosylates or adamantane acid chlorides with mono- and diaza-18-crown-6. The prepared compounds showed moderate (monoaza-18-crown-6) to strong (diaza-18-crown-6) antiproliferative and cytotoxic activity on several tumor cell lines, revealing their potential for inhibiting the growth of other tumor cells.
    Type: Application
    Filed: May 13, 2011
    Publication date: October 20, 2011
    Inventors: Marijeta Kralj, Kata Majerski, Tatjana Sumanovac Ramljak, Marko Marjanovic